CMR-FT right atrial strain is a novel predictive indicator in left ventricular noncompaction patients: a multi-center study

CMR-FT右心房应变是左心室致密化不全患者的一种新型预测指标:一项多中心研究

阅读:5

Abstract

OBJECTIVES: Right atrial (RA) strain is increasingly recognized as a significant predictor of adverse events in patients with various cardiovascular conditions. However, the prognostic value of RA strain in patients with left ventricular noncompaction (LVNC) is unclear. The objective of this study was to evaluate the prognostic significance of RA strain derived from cardiac magnetic resonance feature tracking (CMR-FT) in patients with LVNC. METHODS: 394 LVNC patients who underwent CMR at 4 Chinese medical facilities from September 2014 to July 2023 were retrospectively and consecutively included in total. RA strain parameters were obtained using CMR-FT. Major adverse cardiac events (MACEs) were assessed, and all patients were followed up. RESULTS: 156 patients (39.6%) experienced MACEs during a median follow-up of 34 months. At univariable analysis, RA conduit strain was associated with MACE (hazard ratio [HR] 0.88 [95% CI 0.85-0.91]; P < 0.001). RA conduit strain maintained an independent predictor of MACE in a multivariate model that included left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE) (HR 0.89 [95% CI 0.85-0.93]; p < 0.001). Furthermore, adding RA conduit strain to the multivariate model greatly enhanced the prognostic role of endpoint events (C-statistic improvement: 0.766-0.871, Delong test: p < 0.001). Net reclassification index (NRI) (0.201, p < 0.05) and integrated discrimination improvement (IDI) (0.038, p < 0.05) also showed the same trend. CONCLUSION: CMR-FT derived RA conduit strain is a potent independent indicator of major adverse cardiac events in left ventricular noncompaction patients. In addition, RA conduit strain can provide additional prognostic value over the multivariable baseline clinical model.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。